Eric Bjerkholt
CHIEF FINANCIAL OFFICER; Director · 12 filings · Latest: Sep 11, 2026
CERUS CORP
Metagenomi Therapeutics, Inc.
Mirum Pharmaceuticals, Inc.
Surrozen, Inc./DE
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
CERS | BJERKHOLT ERIC | — | Dec 12, 2024 | Proposed Sale | $1.79 | 20,000 | $35.7K | — |
← Previous
Page 2 of 2